5.7(top 5%)
impact factor
490(top 50%)
papers
7.0K(top 20%)
citations
38(top 20%)
h-index
5.9(top 5%)
impact factor
872
all documents
8.4K
doc citations
59(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic EffectsACS Pharmacology and Translational Science2021223
2Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease InhibitorsACS Pharmacology and Translational Science2020194
3Antibacterial and Antiviral Functional Materials: Chemistry and Biological Activity toward Tackling COVID-19-like PandemicsACS Pharmacology and Translational Science2021174
4Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput ScreeningACS Pharmacology and Translational Science2020162
5The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic EffectsACS Pharmacology and Translational Science2021149
6DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in VivoACS Pharmacology and Translational Science2018143
7DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future ChallengesACS Pharmacology and Translational Science2021120
8Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug EffectsACS Pharmacology and Translational Science2021109
9Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing ScreenACS Pharmacology and Translational Science2021101
10Dominant Negative G Proteins Enhance Formation and Purification of Agonist-GPCR-G Protein Complexes for Structure DeterminationACS Pharmacology and Translational Science201896
11An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19ACS Pharmacology and Translational Science202095
12Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped ParticlesACS Pharmacology and Translational Science202094
13Rules of Engagement: GPCRs and G ProteinsACS Pharmacology and Translational Science201893
14New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug DiscoveryACS Pharmacology and Translational Science202080
15Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying ProteinsACS Pharmacology and Translational Science202071
16Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy VolunteersACS Pharmacology and Translational Science202171
17Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: In Vitro and Molecular Docking StudiesACS Pharmacology and Translational Science202067
18The Potential of Antimicrobial Peptides as an Antiviral Therapy against COVID-19ACS Pharmacology and Translational Science202067
19Ultrasound-Responsive Nanocarriers in Cancer Treatment: A ReviewACS Pharmacology and Translational Science202165
20Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening CancerACS Pharmacology and Translational Science202164
21High-Precision Control of Plasma Drug Levels Using Feedback-Controlled DosingACS Pharmacology and Translational Science201862
22Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and BoceprevirACS Pharmacology and Translational Science202162
23Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayACS Pharmacology and Translational Science202060
24Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal GrowthACS Pharmacology and Translational Science202160
25Investigation of the Structure–Activity Relationships of Psilocybin AnaloguesACS Pharmacology and Translational Science202158
26Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life ChangesACS Pharmacology and Translational Science202158
27Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity?ACS Pharmacology and Translational Science202055
28Consciousness, Religion, and Gurus: Pitfalls of Psychedelic MedicineACS Pharmacology and Translational Science202155
29SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae but Not in Taste Buds or Embryonic Oral EpitheliumACS Pharmacology and Translational Science202052
30Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic TherapyACS Pharmacology and Translational Science202151
31The Fundamental Characteristics of a Translational ScientistACS Pharmacology and Translational Science201950
32Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary LeukocytesACS Pharmacology and Translational Science201949
33Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and RemdesivirACS Pharmacology and Translational Science202149
34Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone AmylinACS Pharmacology and Translational Science201848
35Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo ChemistryACS Pharmacology and Translational Science202145
36A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein DynamicsACS Pharmacology and Translational Science202144
37Moving Past Mysticism in Psychedelic ScienceACS Pharmacology and Translational Science202144
38Novel and Potent Dopamine D2 Receptor Go-Protein Biased AgonistsACS Pharmacology and Translational Science201943
39Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19ACS Pharmacology and Translational Science202043
40Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme ActivitiesACS Pharmacology and Translational Science202243
41Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35ACS Pharmacology and Translational Science202042
42Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist ScaffoldsACS Pharmacology and Translational Science202041
43G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational ModificationsACS Pharmacology and Translational Science202041
44The Emerging Role of Adhesion GPCRs in CancerACS Pharmacology and Translational Science202041
45Helminths and COVID-19 Co-Infections: A Neglected Critical ChallengeACS Pharmacology and Translational Science202040
46Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic DiseaseACS Pharmacology and Translational Science202040
47Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19ACS Pharmacology and Translational Science202140
48Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir ParadigmACS Pharmacology and Translational Science202039
49Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer TreatmentACS Pharmacology and Translational Science202139
50The Molecular Control of Calcitonin Receptor SignalingACS Pharmacology and Translational Science201938